Release characterization of dimenhydrinate from an eroding and swelling matrix: Selection of appropriate dissolution apparatus

International Journal of Pharmaceutics

Volumn 293, Issue 1-2, 2005, Pages 35-42

  Missaghi, Shahrzad ^a   Fassihi, Reza ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Dimenhydrinate; Dissolution apparatus; Hydrodynamic effect; Modified release systems; Similarity and difference factors; Swelling and eroding matrix

Indexed keywords

DIMENHYDRINATE; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL; MALTODEXTRIN; METHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; DISSOLUTION; DRUG RELEASE; DRUG SCREENING; HYDRODYNAMICS; IONIZATION; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TABLET FORMULATION; TABLET MATRIX;

EID: 15044361803     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.12.024     Document Type: Article

References (26)

1. L.M. Bocanegra, G.J. Morris, J.T. Jurewicz, and J.W. Mauger Fluid and particle laser Doppler velocity measurements and mass transfer predictions for the USP paddle method dissolution apparatus Drug Develop. Ind. Pharm. 16 1990 1441 1464
2. S. Budavari The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals 12th ed. 1996 Merck & Co. Inc. Whitehouse Station p. 3250
3. J.B. Dressman, G.L. Amidon, C. Reppas, and V. Shah Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms Pharm. Res. 15 1988 11 22
4. T. Dürig, and R. Fassihi Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test J. Contr. Release 67 2000 37 44
5. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 1997a. Guidance for Industry. SUPAC-MR: Modified Release Solid Oral Dosage Forms.
6. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 1997b. Guidance for Industry. Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations.
7. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 1997c. Guidance for Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms.
8. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 2000. Guidance for Industry. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-release Solid Oral Dosage Forms based on a Biopharmaceutics Classification System.
9. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), 2003. Draft Guidance. Guidance for Industry, PAT: A Framework for Innovative Pharmaceutical Manufacturing And Quality Assurance.
10. L. Genc, H. Bilac, and E. Guler Studies on controlled release dimenhydrinate from matrix tablet formulations Pharm. Acta Helv. 74 1999 43 49
11. J. Haystead Study highlights flawed dissolution testing procedure Pharm. Technol. 27 2003 22
12. M. Kamba, Y. Seta, N. Takeda, T. Hamaura, A. Kusai, H. Nakane, and K. Nishimura Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test Int. J. Pharm. 250 2003 99 109
13. N. Khoury, J.W. Mauger, and H. Stephen Dissolution rate studies from a stationary disk/rotating fluid system Pharm. Res. 5 1988 495 500
14. J. Kraemer In vitro dissolution testing of medicated gums AAPSPharmScience 3 2001 3 (abstract)
15. J. Kukura, P.E. Arratia, E.S. Salía, and F.J. Muzzio Engineering tools for understanding the hydrodynamics of dissolution tests Drug Develop. Ind. Pharm. 29 2003 231 239
16. A. Martin, P. Bustamante, and A.H.C. Chun Physical Pharmacy 4th ed. 1993 Lippincott, Williams & Wilkins Baltimore
17. S. Missaghi, and R. Fassihi Design and development of a controlled release formulation for dimenhydrinate via in-situ interactions of charged substances and polymers Proceedings of the AAPS Annual Meeting and Exposition, Poster Presentation 2002
18. S. Missaghi, and R. Fassihi Evaluation and comparison of dissolution profiles for a swelling and eroding dimenhydrinate tablet using USP apparatus I, II, and III Proceedings of the AAPS Annual Meeting and Exposition, Poster Presentation 2003
19. J.W. Moore, and H.H. Flanner Mathematical comparison of dissolution profiles Pharm. Technol. 20 1996 64 69
20. V. Pillay, and R. Fassihi Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method J. Contr. Release 55 1998 45 55
21. Pillay, V., 2000. Novel formulation approaches in the design strategy, development and evaluation of oral controlled release drug delivery systems. Ph.D. Thesis. Temple University School of Pharmacy, USA.
22. S.A. Qureshi, and I.J. McGilveray A critical assessment of the USP dissolution apparatus suitability test criteria Drug Develop. Ind. Pharm. 21 1995 905 924
23. 2 Pharm. Res. 15 1998 889 896
24. US Pharmacopeia XXVII, 2004. US Pharmacopeial Convention. Rockville, MD, pp. 628-631.
25. WholeHealthMD, 2000. WholeHealthMD.com, LLC. http://www.wholehealthmd. com.
26. L. Yang, and R. Fassihi Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system J. Pharm. Pharmacol. 55 2003 1331 1337